<unk> , sold under the brand name Stalevo among others, is a dopaminergic fixed-dose combination medication that contains<unk> ,<unk> , and<unk>  for the treatment of Parkinson's disease. It is marketed by Swiss-based Novartis Pharmaceuticals and manufactured by Finnish drugmaker Orion Corporation.
Carbidopa/levodopa/entacapone
Fluorodopa
Bromperidol decanoate
Donepezil
3-Quinuclidinyl benzilate
Protriptyline
Perhexiline
Rivastigmine